Virulence of pandemic (H1N1) 2009 influenza A polymerase reassortant viruses
Min-Suk Song1, Philippe Noriel Q Pascua, Young Ki Choi
1Department of Microbiology, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongiu, Republic of Korea.
Abstract:
Infections due to the pandemic (H1N1) 2009 influenza A viruses have been considerably mild relative to previous pandemics. However, its continued circulation among human and animal populations heightened concerns for the generation of virulent variants with greater threat to public health. Thus, we explored the potential role of the influenza viral polymerases, including known molecular markers, in altering the virulence phenotype of the 2009 pandemic A/California/04/09 (CA04, H1N1) virus. By examining in vitro polymerase activities and in vivo pathogenicities in mice model, we were able to show that individual or simultaneous expression of virulence factors in PB2, PB1, and PA might not significantly elevate pathogenicity. Nevertheless, we demonstrated that PB2(627K) or PA(97I) derived from different genetic backgrounds and other unknown polymerase markers have the potential to enhance virulence of CA04. Virus rescue and replication studies identified PA as a critical factor in maintaining genetic stability of the CA04 (H1N1) virus.
Insights
The 2009 H1N1 influenza virus showed mild infections, but concerns about virulence remain. Specific viral polymerase markers, like PB2(627K) and PA(97I), can increase H1N1 virulence, with PA being key for viral stability.
Area of Science:
- Virology
- Molecular Biology
- Public Health
Background:
- The 2009 pandemic H1N1 influenza A virus caused milder infections than previous pandemics.
- Continued circulation in human and animal populations raises concerns about the emergence of more virulent strains.
Purpose of the Study:
- To investigate the role of influenza viral polymerases and known molecular markers in altering the virulence of the 2009 pandemic A/California/04/09 (CA04, H1N1) virus.
- To identify specific viral components that may contribute to increased pathogenicity.
Main Methods:
- In vitro analysis of viral polymerase activities.
- In vivo pathogenicity studies using a mouse model.
- Virus rescue and replication experiments.
Main Results:
- Individual or combined expression of virulence factors in PB2, PB1, and PA did not significantly increase pathogenicity.
- Specific markers PB2(627K) and PA(97I), from different genetic backgrounds, showed potential to enhance CA04 virulence.
- The PA protein was identified as critical for maintaining the genetic stability of the CA04 (H1N1) virus.
Conclusions:
- While some polymerase markers may not significantly increase pathogenicity, specific variants like PB2(627K) and PA(97I) can enhance H1N1 virulence.
- The PA protein plays a crucial role in the genetic stability of the pandemic H1N1 virus, impacting its potential for public health threats.
More Related Videos
07:15Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity
Published on: November 22, 2021
12:18Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System
Published on: November 6, 2013
Related Concept Videos
Influenza
Viral Recombination
Viral Mutations
Leaky Scanning
Infectious Diseases and Their Occurrence
Inhibitors Of Virion Release
